168 related articles for article (PubMed ID: 38155405)
41. Concomitant Kaposi sarcoma and multicentric Castleman's disease in a heart transplant recipient.
Patel A; Bishburg E; Zucker M; Tsang P; Nagarakanti S; Sabnani I
Heart Lung; 2014; 43(6):506-9. PubMed ID: 25169666
[TBL] [Abstract][Full Text] [Related]
42. Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.
Gaidano G; Castaños-Velez E; Biberfeld P
Med Oncol; 1999 Apr; 16(1):8-12. PubMed ID: 10382936
[TBL] [Abstract][Full Text] [Related]
43. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12).
Muralidhar S; Veytsmann G; Chandran B; Ablashi D; Doniger J; Rosenthal LJ
J Clin Virol; 2000 May; 16(3):203-13. PubMed ID: 10738139
[TBL] [Abstract][Full Text] [Related]
44. Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus).
Deng H; Song MJ; Chu JT; Sun R
J Virol; 2002 Aug; 76(16):8252-64. PubMed ID: 12134031
[TBL] [Abstract][Full Text] [Related]
45. Viral, immunologic, and clinical features of primary effusion lymphoma.
Lurain K; Polizzotto MN; Aleman K; Bhutani M; Wyvill KM; Gonçalves PH; Ramaswami R; Marshall VA; Miley W; Steinberg SM; Little RF; Wilson W; Filie AC; Pittaluga S; Jaffe ES; Whitby D; Yarchoan R; Uldrick TS
Blood; 2019 Apr; 133(16):1753-1761. PubMed ID: 30782610
[TBL] [Abstract][Full Text] [Related]
46. Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus.
Nalwoga A; Whitby D
Curr Opin Immunol; 2022 Aug; 77():102230. PubMed ID: 35810680
[TBL] [Abstract][Full Text] [Related]
47. Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies.
Patel R; Lurain K; Yarchoan R; Ramaswami R
Expert Rev Anti Infect Ther; 2023; 21(9):929-941. PubMed ID: 37578202
[TBL] [Abstract][Full Text] [Related]
48. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
49. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
Wen KW; Damania B
Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
[TBL] [Abstract][Full Text] [Related]
50. Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis.
Barrett L; Chen J; Dai L; Plaisance-Bonstaff K; Del Valle L; Qin Z
Front Cell Infect Microbiol; 2020; 10():587929. PubMed ID: 33194830
[TBL] [Abstract][Full Text] [Related]
51. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
52. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
[TBL] [Abstract][Full Text] [Related]
53. Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma.
Burbelo PD; Issa AT; Ching KH; Wyvill KM; Little RF; Iadarola MJ; Kovacs JA; Yarchoan R
J Infect Dis; 2010 Jun; 201(12):1919-22. PubMed ID: 20443737
[TBL] [Abstract][Full Text] [Related]
54. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.
Powles T; Stebbing J; Bazeos A; Hatzimichael E; Mandalia S; Nelson M; Gazzard B; Bower M
Ann Oncol; 2009 Apr; 20(4):775-9. PubMed ID: 19179554
[TBL] [Abstract][Full Text] [Related]
55. 18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters.
Polizzotto MN; Millo C; Uldrick TS; Aleman K; Whatley M; Wyvill KM; O'Mahony D; Marshall V; Whitby D; Maass-Moreno R; Steinberg SM; Little RF; Yarchoan R
J Infect Dis; 2015 Oct; 212(8):1250-60. PubMed ID: 25828248
[TBL] [Abstract][Full Text] [Related]
56. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
[TBL] [Abstract][Full Text] [Related]
57. Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis.
Gasperini P; Sakakibara S; Tosato G
J Leukoc Biol; 2008 Oct; 84(4):994-1000. PubMed ID: 18319288
[TBL] [Abstract][Full Text] [Related]
58. Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case.
Kim B; Jeon YK; Kim CW
J Korean Med Sci; 2009 Oct; 24(5):970-4. PubMed ID: 19795003
[TBL] [Abstract][Full Text] [Related]
59. Castleman's disease and primary effusion lymphoma in a HIV-positive patient.
Scott MJ; Alhariri BC; Farghaly H; Perez R; Arnold FW
Int J STD AIDS; 2014 May; 25(6):455-7. PubMed ID: 24287026
[TBL] [Abstract][Full Text] [Related]
60. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
